BOOM

Trending Searches

    SUPPORT
    BOOM

    Trending News

      • Fact Check 
        • Fast Check
        • Politics
        • Business
        • Entertainment
        • Social
        • Sports
        • World
      • Law
      • Explainers
      • News 
        • All News
      • Decode 
        • Impact
        • Scamcheck
        • Life
        • Voices
      • Media Buddhi 
        • Digital Buddhi
        • Senior Citizens
        • Videos
      • Web Stories
      • BOOM Research
      • BOOM Labs
      • Deepfake Tracker
      • Videos 
        • Facts Neeti
      • Home-icon
        Home
      • About Us-icon
        About Us
      • Authors-icon
        Authors
      • Team-icon
        Team
      • Careers-icon
        Careers
      • Internship-icon
        Internship
      • Contact Us-icon
        Contact Us
      • Methodology-icon
        Methodology
      • Correction Policy-icon
        Correction Policy
      • Non-Partnership Policy-icon
        Non-Partnership Policy
      • Cookie Policy-icon
        Cookie Policy
      • Grievance Redressal-icon
        Grievance Redressal
      • Republishing Guidelines-icon
        Republishing Guidelines
      • Fact Check-icon
        Fact Check
        Fast Check
        Politics
        Business
        Entertainment
        Social
        Sports
        World
      • Law-icon
        Law
      • Explainers-icon
        Explainers
      • News-icon
        News
        All News
      • Decode-icon
        Decode
        Impact
        Scamcheck
        Life
        Voices
      • Media Buddhi-icon
        Media Buddhi
        Digital Buddhi
        Senior Citizens
        Videos
      • Web Stories-icon
        Web Stories
      • BOOM Research-icon
        BOOM Research
      • BOOM Labs-icon
        BOOM Labs
      • Deepfake Tracker-icon
        Deepfake Tracker
      • Videos-icon
        Videos
        Facts Neeti
      Trending Tags
      TRENDING
      • #Operation Sindoor
      • #Pahalgam Terror Attack
      • #Narendra Modi
      • #Rahul Gandhi
      • #Waqf Amendment Bill
      • #Arvind Kejriwal
      • #Deepfake
      • #Artificial Intelligence
      • Home
      • Coronavirus
      • Bharat Biotech Denies Reports Of...
      Coronavirus

      Bharat Biotech Denies Reports Of Sharing Phase 3 Covaxin Data With WHO

      Without WHO emergency use listing, countries like US do not identify Covaxin as a potential vaccine and have also asked people to get re-vaccinated if they have received Covaxin

      By - Shachi Sutaria |
      Published -  18 Jun 2021 2:29 PM IST
    • Boomlive
      Bharat Biotech Denies Reports Of Sharing Phase 3 Covaxin Data With WHO

      Hyderabad based Bharat Biotech has denied reports stating that it has shared its Phase 3 trial results of Covaxin to the World Health Organisation for Emergency Use Listing.

      Bharat Biotech took to Twitter to clarify that reports by media organisations suggesting that it had not submitted Phase 3 trial datawith WHO and this news was reported without any evidence. The company which indigenously produced Covaxin in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is yet to share its Phase 3 trials data which will denote its final efficacy. The newspaper reports also claimed that the company was meeting the WHO on June 23 for receiving Emergency Use Listing.

      The news reports on Bharat Biotech submitting Phase-3 data to WHO is incorrect and lacks any evidence.

      — BharatBiotech (@BharatBiotech) June 17, 2021

      India approved Covaxin for Emergency Use Authorisation without waiting for its Phase 3 results and this move was criticised by several scientists. With the lack of data, the US Food and Drug Administration also asked the company's American partner to provide more data and apply for complete authorisation and did not give it an EUA.

      Also Read:Why India's Homegrown Covaxin Faced Rejection From US FDA

      Many US universities also wrote to its students that they would have to be re-vaccinated. if they had received Covaxin or Russia's Sputnik V. These universities stated the lack of approval by the US FDA, WHO and the Europeran Union as a reason for pushing re-vaccination.

      The WHO has approved the Oxford-AstraZeneca vaccine produced by SK Bio in Korea and Serum Institute of India, the Pfizer-BioNTech vaccine, the Moderna vaccine, the Jannsen vaccine, and the Sinopharm vaccine as emergency use listings. This allows the vaccine manufacturers to distribute their vaccines across the world.

      The Indian manufacturers stated that they would be sharing their Phase 3 trial data with the Subject Expert Committee of the Central Drugs Standard Control Organisation, the Indian drug regulating body in July.

      On June 16, 2021, the company also refuted rumours that the vaccine contained new born calf serum in it.

      Also Read:Health Ministry, Bharat Biotech Deny Covaxin Has New Born Calf Serum


      Tags

      covaxinbharat biotechCOVID-19WHO
      Read Full Article
      Next Story
      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.
      X

      Subscribe to BOOM Newsletters

      👉 No spam, no paywall — but verified insights.

      Please enter a Email Address
      Subscribe for free!

      Stay Ahead of Misinformation!

      Please enter a Email Address
      Subscribe Now🛡️ 100% Privacy Protected | No Spam, Just Facts
      By subscribing, you agree with the Terms & conditions and Privacy Policy connected to the offer

      Thank you for subscribing!

      You’re now part of the BOOM community.

      Or, Subscribe to receive latest news via email
      Subscribed Successfully...
      Copy HTMLHTML is copied!
      There's no data to copy!